메뉴 건너뛰기




Volumn 72, Issue 21, 2012, Pages 5625-5634

Cross-talk between HER2 and MED1 regulates tamoxifen resistance of human breast cancer cells

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEAR RECEPTOR COREPRESSOR; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR; TAMOXIFEN;

EID: 84868228009     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-1305     Document Type: Article
Times cited : (80)

References (49)
  • 1
    • 0033305438 scopus 로고    scopus 로고
    • Estrogen receptor null mice: What have we learned and where will they lead us?
    • Couse JF, Korach KS. Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 1999;20:358-417.
    • (1999) Endocr Rev , vol.20 , pp. 358-417
    • Couse, J.F.1    Korach, K.S.2
  • 2
    • 0033649417 scopus 로고    scopus 로고
    • Developmental, cellular, and molecular basis of human breast cancer
    • Russo J, Hu YF, Yang X, Russo IH. Developmental, cellular, and molecular basis of human breast cancer. J Natl Cancer Inst Monogr 2000;(27):17-37.
    • (2000) J Natl Cancer Inst Monogr , vol.27 , pp. 17-37
    • Russo, J.1    Hu, Y.F.2    Yang, X.3    Russo, I.H.4
  • 3
    • 0035945656 scopus 로고    scopus 로고
    • Estrogen and the risk of breast cancer
    • Clemons M, Goss P. Estrogen and the risk of breast cancer. N Engl J Med 2001;344:276-85.
    • (2001) N Engl J Med , vol.344 , pp. 276-285
    • Clemons, M.1    Goss, P.2
  • 5
    • 30944469849 scopus 로고    scopus 로고
    • Estrogen carcinogenesis in breast cancer
    • Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med 2006;354:270-82.
    • (2006) N Engl J Med , vol.354 , pp. 270-282
    • Yager, J.D.1    Davidson, N.E.2
  • 7
    • 0036488531 scopus 로고    scopus 로고
    • Endocrine-responsive breast cancer and strate-gies for combating resistance
    • Ali S, Coombes RC. Endocrine-responsive breast cancer and strate-gies for combating resistance. Nat Rev Cancer 2002;2:101-12.
    • (2002) Nat Rev Cancer , vol.2 , pp. 101-112
    • Ali, S.1    Coombes, R.C.2
  • 8
    • 0037434618 scopus 로고    scopus 로고
    • Selective estrogen-receptor modulators -mechanismsof action and application toclinical practice
    • Riggs BL, Hartmann LC. Selective estrogen-receptor modulators -mechanismsof action and application toclinical practice. N Engl J Med 2003;348:618-29.
    • (2003) N Engl J Med , vol.348 , pp. 618-629
    • Riggs, B.L.1    Hartmann, L.C.2
  • 9
    • 38449122235 scopus 로고    scopus 로고
    • Estrogen receptors in resistance to hormone therapy
    • Herynk MH, Fuqua SA. Estrogen receptors in resistance to hormone therapy. Adv Exp Med Biol 2007;608:130M43.
    • (2007) Adv Exp Med Biol , vol.608
    • Herynk, M.H.1    Fuqua, S.A.2
  • 10
    • 79551576468 scopus 로고    scopus 로고
    • Mechanisms of endocrine resistance in breast cancer
    • Osborne CK, Schiff R. Mechanisms of endocrine resistance in breast cancer. Annu Rev Med 2011;62:233-47.
    • (2011) Annu Rev Med , vol.62 , pp. 233-247
    • Osborne, C.K.1    Schiff, R.2
  • 11
    • 12144269500 scopus 로고    scopus 로고
    • Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer
    • Osborne CK, Shou J, Massarweh S, Schiff R. Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer. Clin Cancer Res 2005;11:865s-70s.
    • (2005) Clin Cancer Res , vol.11
    • Osborne, C.K.1    Shou, J.2    Massarweh, S.3    Schiff, R.4
  • 12
    • 25844500946 scopus 로고    scopus 로고
    • Consensus statement. Workshop on therapeutic resistance in breast cancer: Impact of growth factor signalling pathways and impli-cations for future treatment
    • Gee JM, Howell A, Gullick WJ, Benz CC, Sutherland RL, Santen RJ, et al. Consensus statement. Workshop on therapeutic resistance in breast cancer: impact of growth factor signalling pathways and impli-cations for future treatment. Endocr Relat Cancer 2005;12 Suppl 1: S1-7.
    • (2005) Endocr Relat Cancer , vol.12 , Issue.SUPPL. 1
    • Gee, J.M.1    Howell, A.2    Gullick, W.J.3    Benz, C.C.4    Sutherland, R.L.5    Santen, R.J.6
  • 13
    • 34347395733 scopus 로고    scopus 로고
    • Trastuzumab-mechanism of action and use in clinical practice
    • Hudis CA. Trastuzumab-mechanism of action and use in clinical practice. N Engl J Med 2007;357:39-51.
    • (2007) N Engl J Med , vol.357 , pp. 39-51
    • Hudis, C.A.1
  • 14
    • 0034667395 scopus 로고    scopus 로고
    • Inhibition of HER2/neu (erb B-2) and mitogen-activat-ed protein kinases enhances tamoxifen action against HER2-over-expressing, tamoxifen-resistant breast cancer cells
    • Kurokawa H, Lenferink AE, Simpson JF, Pisacane PI, Sliwkowski MX, Forbes JT, et al. Inhibition of HER2/neu (erb B-2) and mitogen-activat-ed protein kinases enhances tamoxifen action against HER2-over-expressing, tamoxifen-resistant breast cancer cells. Cancer Res 2000;60:5887-94.
    • (2000) Cancer Res , vol.60 , pp. 5887-5894
    • Kurokawa, H.1    Lenferink, A.E.2    Simpson, J.F.3    Pisacane, P.I.4    Sliwkowski, M.X.5    Forbes, J.T.6
  • 16
    • 2942652871 scopus 로고    scopus 로고
    • Mechanisms of tamoxifen resistance: Increased estrogen receptor-her2neu cross-talk in erher2-positive breast cancer
    • Shou J, Massarweh S, Osborne CK, Wakeling AE, Ali S, Weiss H, et al. Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer. J Natl Can-cer Inst 2004;96:926-35.
    • (2004) J Natl Can-cer Inst , vol.96 , pp. 926-935
    • Shou, J.1    Massarweh, S.2    Osborne, C.K.3    Wakeling, A.E.4    Ali, S.5    Weiss, H.6
  • 17
    • 4444278403 scopus 로고    scopus 로고
    • HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: A southwest oncology group study
    • Arpino G, Green SJ, Allred DC, Lew D, Martino S, Osborne CK, et al. HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: a southwest oncology group study. Clin Cancer Res 2004;10:5670-6.
    • (2004) Clin Cancer Res , vol.10 , pp. 5670-5676
    • Arpino, G.1    Green, S.J.2    Allred, D.C.3    Lew, D.4    Martino, S.5    Osborne, C.K.6
  • 18
    • 0031015394 scopus 로고    scopus 로고
    • Enhanced anti-prolifer-ative activity of the combination of tamoxifen plus HER-2-neu anti-body
    • Witters LM, Kumar R, Chinchilli VM, Lipton A. Enhanced anti-prolifer-ative activity of the combination of tamoxifen plus HER-2-neu anti-body. Breast Cancer Res Treat 1997;42:1-5.
    • (1997) Breast Cancer Res Treat , vol.42 , pp. 1-5
    • Witters, L.M.1    Kumar, R.2    Chinchilli, V.M.3    Lipton, A.4
  • 20
    • 0033050838 scopus 로고    scopus 로고
    • Tamoxifen resistant breast cancer: Coregulators determine the direction of transcription by antagonist-occupied steroid receptors
    • Takimoto GS, Graham JD, Jackson TA, Tung L, Powell RL, Horwitz LD, et al. Tamoxifen resistant breast cancer: coregulators determine the direction of transcription by antagonist-occupied steroid receptors. J Steroid Biochem Mol Biol 1999;69:45-50.
    • (1999) J Steroid Biochem Mol Biol , vol.69 , pp. 45-50
    • Takimoto, G.S.1    Graham, J.D.2    Jackson, T.A.3    Tung, L.4    Powell, R.L.5    Horwitz, L.D.6
  • 21
    • 0001392322 scopus 로고    scopus 로고
    • AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor
    • Font de Mora J, Brown M. AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. Mol Cell Biol 2000;20:5041-7.
    • (2000) Mol Cell Biol , vol.20 , pp. 5041-5047
    • Font De Mora, J.1    Brown, M.2
  • 22
    • 0037420192 scopus 로고    scopus 로고
    • Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer
    • Osborne CK, Bardou V, Hopp TA, Chamness GC, Hilsenbeck SG, Fuqua SA, et al.Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer. J Natl Cancer Inst 2003;95:353-61.
    • (2003) J Natl Cancer Inst , vol.95 , pp. 353-361
    • Osborne, C.K.1    Bardou, V.2    Hopp, T.A.3    Chamness, G.C.4    Hilsenbeck, S.G.5    Fuqua, S.A.6
  • 23
    • 0030249381 scopus 로고    scopus 로고
    • Theroleofgeneralinitiationfactorsintranscriptionby RNA polymerase II
    • Roeder RG.Theroleofgeneralinitiationfactorsintranscriptionby RNA polymerase II. Trends Biochem Sci 1996;21:327-35.
    • (1996) Trends Biochem Sci , vol.21 , pp. 327-335
    • Roeder, R.G.1
  • 24
    • 0032450899 scopus 로고    scopus 로고
    • Role of general and gene-specific cofactors in the regu-lation of eukaryotic transcription
    • Roeder RG. Role of general and gene-specific cofactors in the regu-lation of eukaryotic transcription. Cold Spring Harb Symp Quant Biol 1998;63:201-18.
    • (1998) Cold Spring Harb Symp Quant Biol , vol.63 , pp. 201-218
    • Roeder, R.G.1
  • 25
    • 13044271699 scopus 로고    scopus 로고
    • Amplification and overexpression of peroxisome proliferator-activated receptor binding protein (PBP/PPARBP) gene in breast cancer
    • Zhu Y, Qi C, Jain S, Le Beau MM, Espinosa R III, Atkins GB, et al. Amplification and overexpression of peroxisome proliferator-activated receptor binding protein (PBP/PPARBP) gene in breast cancer. Proc Natl Acad Sci U S A 1999;96:10848-53.
    • (1999) Proc Natl Acad Sci U S A , vol.96 , pp. 10848-10853
    • Zhu, Y.1    Qi, C.2    Jain, S.3    Le Beau, M.M.4    Espinosa Iii., R.5    Atkins, G.B.6
  • 26
    • 0034617082 scopus 로고    scopus 로고
    • Func-tional interactions between the estrogen receptor and DRIP205, a subunit of the heteromeric DRIP coactivator complex
    • Burakov D, Wong CW, Rachez C, Cheskis BJ, Freedman LP. Func-tional interactions between the estrogen receptor and DRIP205, a subunit of the heteromeric DRIP coactivator complex. J Biol Chem 2000;275:20928-34.
    • (2000) J Biol Chem , vol.275 , pp. 20928-20934
    • Burakov, D.1    Wong, C.W.2    Rachez, C.3    Cheskis, B.J.4    Freedman, L.P.5
  • 27
    • 0035968333 scopus 로고    scopus 로고
    • Differential recruitment of the mammalian mediator subunit TRAP220 by estrogen receptors ERalpha and ERbeta
    • Warnmark A, Almlof T, Leers J, Gustafsson JA, Treuter E. Differential recruitment of the mammalian mediator subunit TRAP220 by estrogen receptors ERalpha and ERbeta. J Biol Chem 2001;276:23397-404.
    • (2001) J Biol Chem , vol.276 , pp. 23397-23404
    • Warnmark, A.1    Almlof, T.2    Leers, J.3    Gustafsson, J.A.4    Treuter, E.5
  • 28
    • 0037022631 scopus 로고    scopus 로고
    • The TRAP/Mediator coactivator complex interacts directly with estrogen receptors alphaand betathroughthe TRAP220subunitand directlyenhances estrogen receptor function in vitro
    • Kang YK, Guermah M, Yuan CX, Roeder RG. The TRAP/Mediator coactivator complex interacts directly with estrogen receptors alphaand betathroughthe TRAP220subunitand directlyenhances estrogen receptor function in vitro. Proc Natl Acad Sci U S A 2002;99:2642-7.
    • (2002) Proc Natl Acad Sci U S A , vol.99 , pp. 2642-2647
    • Kang, Y.K.1    Guermah, M.2    Yuan, C.X.3    Roeder, R.G.4
  • 29
    • 21244466640 scopus 로고    scopus 로고
    • MED1/TRAP220 exists predominantly in a TRAP/Mediator sub-population enriched in RNA polymerase II and is required for ER-mediated transcription
    • Zhang X, Krutchinsky A, Fukuda A, Chen W, Yamamura S, Chait BT, et al. MED1/TRAP220 exists predominantly in a TRAP/Mediator sub-population enriched in RNA polymerase II and is required for ER-mediated transcription. Mol Cell 2005;19:89-100.
    • (2005) Mol Cell , vol.19 , pp. 89-100
    • Zhang, X.1    Krutchinsky, A.2    Fukuda, A.3    Chen, W.4    Yamamura, S.5    Chait, B.T.6
  • 30
    • 77951032219 scopus 로고    scopus 로고
    • Keyrolesfor MED1 Lxx LL motifs in pubertal mammary gland development and luminal-cell differentiation
    • Jiang P, Hu Q, Ito M, Meyer S, Waltz S, Khan S, et al. Keyrolesfor MED1 Lxx LL motifs in pubertal mammary gland development and luminal-cell differentiation. Proc Natl Acad Sci U S A 2010;107:6765-70.
    • (2010) Proc Natl Acad Sci U S A , vol.107 , pp. 6765-6770
    • Jiang, P.1    Hu, Q.2    Ito, M.3    Meyer, S.4    Waltz, S.5    Khan, S.6
  • 31
    • 2242451441 scopus 로고    scopus 로고
    • Phosphorylation of transcriptional coactivator peroxisome proliferator-activated receptor (PPAR)-binding protein (PBP). Stimulation of transcriptional regulation by mitogen-activated protein kinase
    • Misra P, Owuor ED, Li W, Yu S, Qi C, Meyer K, et al. Phosphorylation of transcriptional coactivator peroxisome proliferator-activated receptor (PPAR)-binding protein (PBP). Stimulation of transcriptional regulation by mitogen-activated protein kinase. J Biol Chem 2002;277:48745-54.
    • (2002) J Biol Chem , vol.277 , pp. 48745-48754
    • Misra, P.1    Owuor, E.D.2    Li, W.3    Yu, S.4    Qi, C.5    Meyer, K.6
  • 32
    • 28544440730 scopus 로고    scopus 로고
    • Activation of TRAP/mediatorsubunit TRAP220/Med1 is regulated by mitogen-activated protein kinase-dependent phosphorylation
    • Pandey PK, Udayakumar TS, Lin X, Sharma D, Shapiro PS, Fondell JD. Activation of TRAP/mediatorsubunit TRAP220/Med1 is regulated by mitogen-activated protein kinase-dependent phosphorylation. Mol Cell Biol 2005;25:10695-710.
    • (2005) Mol Cell Biol , vol.25 , pp. 10695-10710
    • Pandey, P.K.1    Udayakumar, T.S.2    Lin, X.3    Sharma, D.4    Shapiro, P.S.5    Fondell, J.D.6
  • 33
    • 44949188489 scopus 로고    scopus 로고
    • MED1 phos-phorylation promotes its association with mediator: Implications for nuclear receptorsignaling
    • Belakavadi M, Pandey PK, Vijayvargia R, Fondell JD. MED1 phos-phorylation promotes its association with mediator: implications for nuclear receptorsignaling. Mol Cell Biol 2008;28:3932-42.
    • (2008) Mol Cell Biol , vol.28 , pp. 3932-3942
    • Belakavadi, M.1    Pandey, P.K.2    Vijayvargia, R.3    Fondell, J.D.4
  • 34
    • 79958864543 scopus 로고    scopus 로고
    • Phospho-MED1-enhanced UBE2C locus looping drives castration-resistant prostate cancer growth
    • Chen Z, Zhang C, Wu D, Chen H, Rorick A, Zhang X, et al. Phospho-MED1-enhanced UBE2C locus looping drives castration-resistant prostate cancer growth. EMBO J 2011;30:2405-19.
    • (2011) EMBO J , vol.30 , pp. 2405-2419
    • Chen, Z.1    Zhang, C.2    Wu, D.3    Chen, H.4    Rorick, A.5    Zhang, X.6
  • 35
    • 0036648452 scopus 로고    scopus 로고
    • Amplification and expression of genes from the 17q11 approximately q12 amplicon in breast cancer cells
    • Luoh SW. Amplification and expression of genes from the 17q11 approximately q12 amplicon in breast cancer cells. Cancer Genet Cytogenet 2002;136:43-7.
    • (2002) Cancer Genet Cytogenet , vol.136 , pp. 43-47
    • Luoh, S.W.1
  • 36
    • 26444546442 scopus 로고    scopus 로고
    • An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival
    • Miller LD, Smeds J, George J, Vega VB, Vergara L, Ploner A, et al. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci U S A 2005;102:13550-5.
    • (2005) Proc Natl Acad Sci U S A , vol.102 , pp. 13550-13555
    • Miller, L.D.1    Smeds, J.2    George, J.3    Vega, V.B.4    Vergara, L.5    Ploner, A.6
  • 37
    • 33751261643 scopus 로고    scopus 로고
    • Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer
    • Ivshina AV, George J, Senko O, Mow B, Putti TC, Smeds J, et al. Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Res 2006;66:10292-301.
    • (2006) Cancer Res , vol.66 , pp. 10292-10301
    • Ivshina, A.V.1    George, J.2    Senko, O.3    Mow, B.4    Putti, T.C.5    Smeds, J.6
  • 38
    • 4544376914 scopus 로고    scopus 로고
    • Binding at and transactivation of the COX-2 promoter by nucleartyrosine kinase receptor Erb B-2
    • Wang SC, Lien HC, Xia W, Chen IF, Lo HW, Wang Z, et al. Binding at and transactivation of the COX-2 promoter by nucleartyrosine kinase receptor Erb B-2. Cancer Cell 2004;6:251-61.
    • (2004) Cancer Cell , vol.6 , pp. 251-261
    • Wang, S.C.1    Lien, H.C.2    Xia, W.3    Chen, I.F.4    Lo, H.W.5    Wang, Z.6
  • 39
    • 79955962062 scopus 로고    scopus 로고
    • ARGLU1 interacts with MED1 and is required forestrogen receptor-mediated genetranscription and breast cancer cell growth
    • Zhang D, Jiang P, Xu Q, Zhang X. ARGLU1 interacts with MED1 and is required forestrogen receptor-mediated genetranscription and breast cancer cell growth. J Biol Chem 2011;286:17746-54.
    • (2011) J Biol Chem , vol.286 , pp. 17746-17754
    • Zhang, D.1    Jiang, P.2    Xu, Q.3    Zhang, X.4
  • 40
    • 77957673898 scopus 로고    scopus 로고
    • Growth factor stimulation induces a distinct ER(alpha) cistrome underlying breast cancer endocrine resistance
    • Lupien M, Meyer CA, Bailey ST, Eeckhoute J, Cook J, Westerling T, et al. Growth factor stimulation induces a distinct ER(alpha) cistrome underlying breast cancer endocrine resistance. Genes Dev 2011;24: 2219-27.
    • (2011) Genes Dev , vol.24 , pp. 2219-2227
    • Lupien, M.1    Meyer, C.A.2    Bailey, S.T.3    Eeckhoute, J.4    Cook, J.5    Westerling, T.6
  • 41
    • 0033637703 scopus 로고    scopus 로고
    • Cofactordynamicsand sufficiency in estrogen receptor-regulated transcription
    • Shang Y, Hu X, Di Renzo J, Lazar MA, Brown M.Cofactordynamicsand sufficiency in estrogen receptor-regulated transcription. Cell 2000;103:843-52.
    • (2000) Cell , vol.103 , pp. 843-852
    • Shang, Y.1    Hu, X.2    Di Renzo, J.3    Ma, L.4    Brown, M.5
  • 43
    • 0030946198 scopus 로고    scopus 로고
    • Coactivator and corepressor regulationoftheagonist/ antagonistactivityofthemixedantiestrogen, 4-hydroxytamoxifen
    • Smith CL, Nawaz Z, O'Malley BW. Coactivator and corepressor regulationoftheagonist/antagonistactivityofthemixedantiestrogen, 4-hydroxytamoxifen. Mol Endocrinol 1997;11:657-66.
    • (1997) Mol Endocrinol , vol.11 , pp. 657-666
    • Smith, C.L.1    Nawaz, Z.2    O'Malley, B.W.3
  • 44
    • 22344435852 scopus 로고    scopus 로고
    • Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-Co R and SMRT
    • Keeton EK, Brown M. Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-Co R and SMRT. Mol Endocrinol 2005;19:1543-54.
    • (2005) Mol Endocrinol , vol.19 , pp. 1543-1554
    • Keeton, E.K.1    Brown, M.2
  • 45
    • 0037192501 scopus 로고    scopus 로고
    • Moleculardeterminantsforthetissuespecificityof SERMs
    • Shang Y, Brown M. Moleculardeterminantsforthetissuespecificityof SERMs. Science 2002;295:2465-8.
    • (2002) Science , vol.295 , pp. 2465-2468
    • Shang, Y.1    Brown, M.2
  • 46
    • 0029877913 scopus 로고    scopus 로고
    • Activation of the unli-ganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation
    • Bunone G, Briand PA, Miksicek RJ, Picard D. Activation of the unli-ganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J 1996;15:2174-83.
    • (1996) EMBO J , vol.15 , pp. 2174-2183
    • Bunone, G.1    Briand, P.A.2    Miksicek, R.J.3    Picard, D.4
  • 47
    • 0035668047 scopus 로고    scopus 로고
    • Cross-talk among estrogen receptor, epidermalgrowthfactor, andinsulin-likegrowthfactorsignalinginbreast cancer
    • discussion 11s-12s
    • Lee AV, Cui X, Oesterreich S. Cross-talk among estrogen receptor, epidermalgrowthfactor, andinsulin-likegrowthfactorsignalinginbreast cancer. Clin Cancer Res 2001;7:4429s-35s; discussion 11s-12s.
    • (2001) Clin Cancer Res , vol.7
    • Lee, A.V.1    Cui, X.2    Oesterreich, S.3
  • 48
    • 51649091930 scopus 로고    scopus 로고
    • Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis
    • Creighton CJ, Casa A, Lazard Z, Huang S, Tsimelzon A, Hilsenbeck SG, et al. Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis. J Clin Oncol 2008;26:4078-85.
    • (2008) J Clin Oncol , vol.26 , pp. 4078-4085
    • Creighton, C.J.1    Casa, A.2    Lazard, Z.3    Huang, S.4    Tsimelzon, A.5    Hilsenbeck, S.G.6
  • 49
    • 84856008906 scopus 로고    scopus 로고
    • Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
    • Ross-Innes CS, Stark R, Teschendorff AE, Holmes KA, Ali HR, Dunning MJ, et al. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature 2012;481:389-93.
    • (2012) Nature , vol.481 , pp. 389-393
    • Ross-Innes, C.S.1    Stark, R.2    Teschendorff, A.E.3    Holmes, K.A.4    Ali, H.R.5    Dunning, M.J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.